Recurrent Esophageal Adenocarcinoma
2 clinical trials · Condition
◉ Watch Recurrent Esophageal Adenocarcinoma
| Record | Firm | Date |
|---|---|---|
| Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer (NCT01142388) | National Cancer Institute (NCI) | 2010-09-21 |
| Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer (NCT01178944) | Roswell Park Cancer Institute | 2010-09-01 |
Track Recurrent Esophageal Adenocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.